Shopping Cart
Remove All
Your shopping cart is currently empty
Beludavimab (BMS 4182137; VIR 7832), a monoclonal antibody, specifically targets the spike glycoprotein of SARS-CoV-2, effectively binding to the receptor-binding domain of the recombinant spike protein (S-RBD) with an equilibrium concentration (EC50) of 14.9 ng/mL and a dissociation constant (Kd) of 0.21 nM [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Beludavimab (BMS 4182137; VIR 7832), a monoclonal antibody, specifically targets the spike glycoprotein of SARS-CoV-2, effectively binding to the receptor-binding domain of the recombinant spike protein (S-RBD) with an equilibrium concentration (EC50) of 14.9 ng/mL and a dissociation constant (Kd) of 0.21 nM [1]. |
| Reactivity | Virus |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 2423016-74-2 |
| Storage | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.